You are viewing a single comment's thread from:

RE: Taking an antiviral drug from lab bench to bedside - Defining the problem statement (Chapter 1)

in StemSocial2 years ago

Thanks for your comment and raising such an interesting and important question. I have found a solution to this by developing the pipeline that specifically increases the chances of screening for those kind of drugs. Though I would leave the details for my next post. Also to answer your question, we don't have to look very far away from nature when looking for those kinds of drugs. Even our body produces these small proteins called antimicrobial peptides (AMPs). Some of these which can specifically bind to viral membrane and which has specific composition and cause agglutination or reduce it's ability to bind to receptors. I have recently communicated a paper on this with a colleague on one such AMP (this AMP is different from solution I have found) and it is currently under review. I will write about it once it is published. Let me know if you have further questions.

Sort:  

nice! great to read about it!